Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls.
Need for the upcoming revision of the current diagnostic criteria for NMO - response to the letter from Zhou et al.
Cholinergic System Dysfunction and Neurodegenerative Diseases: Cause or Effect?
Melatonin treatment improves primary progressive multiple sclerosis: a case report.
[Current state of research on multiple sclerosis].
Kindlin-3 regulates integrin activation and adhesion reinforcement of effector T cells.
Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection.
Using magnetic resonance imaging as a means to study chronic cerebral spinal venous insufficiency in multiple sclerosis patients.
Gut dysfunction in patients with multiple sclerosis and the role of spinal cord involvement in the disease.
Proteasome Inhibitors: A New Perspective for Treating Autoimmune Diseases.
Glucosamine modulates T cell differentiation through downregulating N-linked glycosylation of CD25.
Multiple sclerosis and the blood-central nervous system barrier.
Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy.
Severe relapses under fingolimod treatment prescribed after natalizumab.
The effectiveness of aerobic training, cognitive behavioural therapy, and energy conservation management in treating MS-related fatigue: the design of the TREFAMS-ACE programme.
Experimental autoimmune encephalomyelitis is a good model of multiple sclerosis if used wisely.
Th17 and Non-Classic Th1 Cells in Chronic Inflammatory Disorders: Two Sides of the Same Coin.
Aquaporin water channels in the nervous system.
Spinal cord lesions in patients with clinically isolated syndrome: A powerful tool in diagnosis and prognosis.
Self-rating makes the difference: Identifying palliative care needs of patients feeling severely affected by multiple sclerosis.
Isolated cognitive relapses in multiple sclerosis.
Regulatory T-cell vaccination independent of auto-antigen.
Multiple Sclerosis: Current Knowledge and Future Outlook.
Leber hereditary optic neuropathy and multiple sclerosis: the mitochondrial connection.
Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple sclerosis.
Pages
« first
‹ previous
…
337
338
339
340
341
342
343
344
345
…
next ›
last »